Clinical Trials Logo

Filter by:
NCT ID: NCT02579070 Completed - Diabetic Foot Clinical Trials

Diabetic Foot Ulcer Prevention System (DFUPS) - Part 2

DFUPS
Start date: February 8, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether regular measurement of skin foot temperature with a novel device (DFUPS) will prevent ulcer recurrence in diabetic patients at high risk of foot ulceration. It is planned to regularly measure the temperature of the feet of people with diabetes who have already had a foot ulcer which has subsequently healed. These measurements should allow the identification of hotspots on the foot and may be helpful when advising about ulcer risk and providing preventative treatment. It is hoped to find out whether the regular use of thermal images taken with the DFUPS device together with standard foot treatment may reduce the number of people with diabetes developing ulcers or even prevent foot ulcers.

NCT ID: NCT02578940 Completed - Clinical trials for Cancer of the Prostate

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer

FALCON
Start date: November 2015
Phase: Phase 3
Study type: Interventional

The main aim is to assess the impact of using 18F-fluciclovine (as a PET imaging radiotracer) on the clinical and treatment decision required for managing patients with biochemically recurrent prostate cancer (BCR) who are being considered for salvage treatment with the intention of providing disease cure. Also, this study will consolidate the information regarding diagnostic performance of fluciclovine PET/CT in a large number of prospectively followed patients at several centres in the UK and assess the effect of PSA level on the likelihood of detecting cancer lesions by 18F-fluciclovine

NCT ID: NCT02578797 Completed - Clinical trials for Castration-Resistant Prostate Cancer

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

Start date: December 18, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether daily treatment with apalutamide affects the ventricular repolarization in participants with Castration-Resistant Prostate Cancer (CRPC)

NCT ID: NCT02578394 Completed - Clinical trials for Chronic Kidney Diseases

Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study

ASGARD
Start date: April 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to determine the feasibility of running a phase III double-blind, double-dummy randomised controlled trial comparing Depo-Medrone 120mg intramuscular injection vs. Anakinra 100mg subcutaneous injection for 5 days for the treatment of acute gout attacks in patients with chronic kidney disease as defined by a eGFR < 60mls/min/1.73m2 and ≥ 30mls/min/1.73m2.

NCT ID: NCT02578381 Completed - Stable Angina Clinical Trials

Boston Scientific COMET Wire Validation Study

COMET
Start date: March 16, 2016
Phase: N/A
Study type: Interventional

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pressure Wire versus Boston Scientific Pressure Wire 3. performance of St Jude Pressure Wire versus St Jude Pressure Wire

NCT ID: NCT02577406 Completed - Leukemia, Myeloid Clinical Trials

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

IDHENTIFY
Start date: December 30, 2015
Phase: Phase 3
Study type: Interventional

This is an international, multicenter, open-label, randomized, Phase 3 study comparing the efficacy and safety of AG-221 versus conventional care regimens (CCRs) in subjects 60 years or older with acute myeloid leukemia (AML) refractory to or relapsed after second- or third-line AML therapy and positive for an isocitrate dehydrogenase (IDH2) mutation.

NCT ID: NCT02577354 Completed - Clinical trials for Chronic Low Back Pain

ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain

ReActiv8-B
Start date: August 2016
Phase: N/A
Study type: Interventional

The purpose of this trial is to evaluate the safety and efficacy of ReActiv8 for the treatment of adults with Chronic Low Back Pain when used in conjunction with medical management.

NCT ID: NCT02577224 Completed - Blepharospasm Clinical Trials

An RCT of a Patient-initiated Treatment Service for BEB and HFS

Start date: August 2015
Phase: N/A
Study type: Interventional

Blepharospasm and hemifacial spasm are debilitating conditions which significantly impact on patient quality of life. Cyclical treatment with botulinum toxin injections offers temporary relief but the duration of treatment efficacy is variable. The standard model of patient care defines routine fixed- time based scheduled treatment cycles which may lead to unnecessarily frequent treatment for some patients and experience of distressing symptoms in others if symptoms return before the scheduled follow up period. The present study aims to compare a patient-initiated model of care, where patients determine treatment timing, with the standard model of care by using a two-arm randomised controlled trial design. It is expected that patients able to initiate their own treatment will experience less variation in disease severity and disability over a treatment cycle as they will be empowered to take the initiative when they feel they need to have treatment. A range of other outcomes will be assessed including: confidence and satisfaction in the service, depression, anxiety, quality of life and, illness and treatment beliefs. If the patient-led care model is shown to be effective in preventing distress and reducing disability in these populations; and is found to be acceptable to service users, this will have significant implications for service organisation across the NHS.

NCT ID: NCT02576860 Completed - Rosacea Clinical Trials

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Start date: October 2015
Phase: Phase 3
Study type: Interventional

This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.

NCT ID: NCT02576847 Completed - Rosacea Clinical Trials

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

Start date: October 2015
Phase: Phase 3
Study type: Interventional

This study evaluates the long-term safety of once-daily application of Omiganan topical gel in subjects with severe papulopustular rosacea.